| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 14.3% | 4.39% | 28.29% | 124/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 11.15% | -16.62% | 5.8% | 127/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 10.54% | -23.3% | -7.24% | 127/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 11.36% | -11.59% | -17.08% | 127/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 13.7% | 20.05% | 2.47% | 125/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 13.37% | 10.51% | -2.68% | 127/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 13.74% | 9.55% | 6.91% | 123/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 12.85% | 15.63% | 12.6% | 127/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 11.41% | 47.01% | -5.68% | 122/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 12.1% | 24.78% | -3.52% | 127/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 12.54% | 16.16% | 12.84% | 121/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 11.11% | -33% | 43.16% | 125/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 7.76% | -61.69% | -19.94% | 121/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 9.7% | -84.25% | -10.19% | 129/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 10.8% | -83.89% | -34.91% | 117/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 16.59% | -77.02% | -18.14% | 122/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 20.26% | -72.91% | -67.09% | 106/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 61.56% | -13.09% | -8.17% | 62/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 67.03% | 2% | -7.14% | 41/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 72.19% | 36.52% | -3.47% | 33/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 74.79% | 198.37% | 5.58% | 23/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 70.83% | 275.69% | 33.96% | 42/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-06-30 | 52.88% | 239.26% | 110.96% | 76/140 | 60.36% | 正海生物 | 92.23% | 行业排名> |
| 2020-03-31 | 25.06% | 2% | 32.94% | 74/140 | 58.8% | 正海生物 | 92.69% | 行业排名> |
| 2019-12-31 | 18.85% | 7.83% | 7.83% | 118/140 | 56.96% | 正海生物 | 92.61% | 行业排名> |
| 2018-12-31 | 17.49% | -8.69% | 12.19% | 112/140 | 56.22% | 正海生物 | 94.38% | 行业排名> |
| 2018-06-30 | 15.59% | -23.81% | -18.61% | 61/140 | 53.06% | 正海生物 | 93.12% | 行业排名> |
| 2017-12-31 | 19.15% | 8.54% | -6.39% | 104/140 | 56.1% | 正海生物 | 93.78% | 行业排名> |
| 2017-06-30 | 20.46% | 1.56% | 15.95% | 58/140 | 54.85% | 正海生物 | 93.09% | 行业排名> |
| 2016-12-31 | 17.64% | -21.56% | -12.4% | 79/140 | 57.35% | 正海生物 | 93.85% | 行业排名> |
| 2016-06-30 | 20.14% | -10.73% | -10.46% | 50/140 | 52.6% | 正海生物 | 93.08% | 行业排名> |

微信公众号
证券之星APP


